Buprenorphine clinical trials
Also written Butrans™, Subutex, RBP-6000 and EN3409.
Includes 16 studies of Sublocade.
Counted the way a researcher would: Buprenorphine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Buprenorphine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Buprenorphine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 1981 · BUPRENEX · NDA 018401 (FDA, Drugs@FDA)
- European Union
- 26 Sept 2006 · Suboxone · EMEA/H/C/000697 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
308 studies that test it; most in 2012 (19); 4 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1991 | 3 |
| 1992 | 10 |
| 1993 | 3 |
| 1994 | 5 |
| 1995 | 4 |
| 1996 | 10 |
| 1997 | 6 |
| 1999 | 5 |
| 2000 | 5 |
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 7 |
| 2004 | 11 |
| 2005 | 6 |
| 2006 | 11 |
| 2007 | 14 |
| 2008 | 15 |
| 2009 | 10 |
| 2010 | 12 |
| 2011 | 12 |
| 2012 | 19 |
| 2013 | 14 |
| 2014 | 9 |
| 2015 | 9 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 10 |
| 2019 | 13 |
| 2020 | 9 |
| 2021 | 9 |
| 2022 | 9 |
| 2023 | 11 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 11 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 99 · Other 226
National Institute on Drug Abuse (NIDA) (43) · Purdue Pharma LP (27) · Indivior Inc. (23) · Yale University (14) · New York State Psychiatric Institute (11) · University of California, Los Angeles (11) · BioDelivery Sciences International (9) · Johns Hopkins University (7)
Often tested with
Tested in the same studies.
Naloxone (56) · Buprenorphine, Naloxone Drug Combination (16) · Naltrexone (12) · Methadone (8) · Vivitrol (5) · Oxycodone (4) · Morphine (4) · Fentanyl (4)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 15, 3 in phase 3
Studies that test Buprenorphine, phase 3 first.
- Jan 2027Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderPhase 2/3 · New York State Psychiatric Institute
- Aug 2027Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of OverdosePhase 2/3 · Rhode Island Hospital
- Sep 2027Standard Versus High Dose ED-Initiated Buprenorphine InductionPhase 3 · Yale University
- Dec 2026Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency DepartmentPhase 1/2 · The Cooper Health System
- Dec 2026Assessing Optimal XRB Initiation Points in JailPhase 4 · NYU Langone Health
- Dec 2026Low-dose Buprenorphine as a Modulator of Social Motivation in SchizophreniaPhase 2 · University of California, Los Angeles
- Dec 2026Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)Phase 2 · NYU Langone Health
- Dec 2026Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl UsePhase 2 · University of Pennsylvania
- Jan 2027Injectable Buprenorphine in Prison: A Preference TrialPhase 4 · Lifespan
- Feb 2027Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy ClinicPhase 4 · Yale University
Studies
Open first, then newest update. How each study uses Buprenorphine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 325
- Low-Dose IV Buprenorphine vs Hydromorphone for Acute Pain in the EDNot yet recruitingPhase 2Stanford UniversityNCT07941505Written as Buprenorphine (BUP)How we know
- Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine InitiationNot yet recruitingPhase 4University of California, San FranciscoNCT07469501Written as Injectable buprenorphineHow we know
- NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral SettingsNot yet recruitingPhase 4Duke UniversityNCT06854029Written as Buprenorphine injectionHow we know
- ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic PainRecruitingPhase 1/2Medical University of South CarolinaNCT06442566Written as Buprenorphine PatchHow we know
- Buprenorphine for the Management of Pain in Children With Sickle Cell DiseaseNot yet recruitingPhase 1Natasha ArcherNCT07799571Written as Buprenorphine Buccal Film [Belbuca]How we know
- Examining Analgesic Synergy and Efficacy in Trauma CareNot yet recruitingPhase 4Wake Forest University Health SciencesNCT07435077Written as BuprenorphineHow we know
- BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)RecruitingPhase 4Icahn School of Medicine at Mount SinaiNCT07786012Written as buprenorphineHow we know
- Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy ClinicRecruitingPhase 4Yale UniversityNCT07176351Written as BuprenorphineHow we know
- A Bundled Intervention to End Opioid OverdosesRecruitingPhase 4University of Alabama at BirminghamNCT07485335Written as Buprenorphine (Experimental)How we know
- Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic SurgeryRecruitingPhase 4Medical University of SilesiaNCT07434427Written as Group B (Buprenorphine)How we know
- Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency DepartmentsRecruitingPhase 2/3University of British ColumbiaNCT04893525Written as Buprenorphine/naloxoneHow we know
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderRecruitingPhase 4VA Office of Research and DevelopmentNCT04375033Written as Sublingual buprenorphine with naloxoneHow we know
- Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee ArthroplastyNot yet recruitingPhase 4Wake Forest University Health SciencesNCT07097493Written as Bupivacaine, Clonidine, Epinephrine, Buprenorphine and Dexamethasone (BPV-CEBD) CombinationHow we know
- Assessing Optimal XRB Initiation Points in JailRecruitingPhase 4NYU Langone HealthNCT06051890Written as Extended-Release Buprenorphine (XRB)How we know
- High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)RecruitingPhase 3Rutgers, The State University of New JerseyNCT05589181Written as High Dose BuprenorphineHow we know
- Analgesia With Transdermal Buprenorphine Patch in Adults Undergoing Video-Assisted Thoracoscopic SurgeryRecruitingNot applicableClínica DávilaNCT07733128Written as Buprenorphine (BUP)How we know
- Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl UseRecruitingPhase 2University of PennsylvaniaNCT06379984Written as BuprenorphineHow we know
- Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency DepartmentRecruitingPhase 1/2The Cooper Health SystemNCT07430345Written as Buprenorphine 0.15 MGHow we know
- A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid UseRecruitingEarly Phase 1Rachel R. LubaNCT06726200Written as Buprenorphine + naloxone (Suboxone)How we know
- Standard Versus High Dose ED-Initiated Buprenorphine InductionRecruitingPhase 3Yale UniversityNCT06494904Written as BuprenorphineHow we know
See all 325 studies that test Buprenorphine →
Given beside what is tested · 25 — Buprenorphine is usual care or a partner of the new treatment
- A Study of Brenipatide in Participants With Opioid Use DisorderRecruitingPhase 2Eli Lilly and CompanyNCT07420283Written as BuprenorphineHow we know
- Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use DisorderRecruitingPhase 2University of British ColumbiaNCT04234191Written as Buprenorphine/naloxoneHow we know
- Buprenorphine Group Medical Visits in Primary CareCompletedPhase 3Montefiore Medical CenterNCT02526212Written as BuprenorphineHow we know
- Onsite Buprenorphine Treatment at Syringe Exchange ProgramsCompletedPhase 2Montefiore Medical CenterNCT03150173Written as BuprenorphineHow we know
- HOPE Consortium Trial to Reduce Pain and Opioid Use in HemodialysisCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT04571619Written as BuprenorphineHow we know
- A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use DisorderCompletedPhase 1Astellas Pharma Global Development, Inc.NCT04447287Written as buprenorphine/naloxoneHow we know
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use DisorderWithdrawnPhase 2Astellas Pharma Global Development, Inc.NCT05062577Written as buprenorphine/naloxoneHow we know
- Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use DisorderCompletedPhase 1Indivior Inc.NCT04976855Written as SUBOXONE® sublingual filmHow we know
- Optimal Treatment of Veterans With PTSD and Comorbid OUDTerminatedPhase 2VA Office of Research and DevelopmentNCT03605342Written as BuprenorphineHow we know
- Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSPCompletedNot applicableDuke UniversityNCT05108935Written as SuboxoneHow we know
- CBT4CBT for Office Based BuprenorphineCompletedPhase 1/2CBT4CBT, LLCNCT03580902Written as Buprenorphine/naloxoneHow we know
- Medication Maintenance Therapy in Community Pharmacy SettingsStatus unknownPhase 2/3LifespanNCT04139213Written as buprenorphine/naloxone oral productHow we know
- Improving Treatment Outcomes for Prescription Opioid DependenceCompletedPhase 2/3University of ArkansasNCT02543944Written as BuprenorphineHow we know
- Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)CompletedNot applicableVirginia Polytechnic Institute and State UniversityNCT00929253Written as SuboxoneHow we know
- Clinical Trial of Integrated Treatment for Pain and Opioid DependenceCompletedPhase 1/2Yale UniversityNCT00634803Written as BuprenorphineHow we know
- Improving Office Based Treatment of Opioid Use Disorder With TechnologyStatus unknownNot applicableMedicaSafe, Inc.NCT03586466Written as Buprenorphine/naloxoneHow we know
- Study of a Novel Subcutaneous Depot Formulation of BuprenorphineCompletedPhase 1Indivior Inc.NCT03715634Written as SL BuprenorphineHow we know
- Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROLCompletedPhase 3Alkermes, Inc.NCT02696434Written as BuprenorphineHow we know
- Improved Strategies for Outpatient Opioid DetoxificationCompletedPhase 1New York State Psychiatric InstituteNCT01377610Written as BuprenorphineHow we know
- A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/NaloxoneCompletedPhase 1ViiV HealthcareNCT02666001Written as Buprenorphine and NorbuprenorphineHow we know
Showing 20 of 25.
As the comparator · 8 — what is tested is compared with Buprenorphine
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.RecruitingPhase 4Yale UniversityNCT06323824Written as Buprenorphine (BUP)How we know
- Extended Release Naltrexone for Opioid-Dependent YouthCompletedPhase 4Friends Research Institute, Inc.NCT01843023Written as BuprenorphineHow we know
- Comparison of Three Opioid Detoxification Treatment RegimensWithdrawnPhase 3University of Alabama at BirminghamNCT03678792Written as Buprenorphine/naloxoneHow we know
- Medications Development for Drug Abuse DisordersCompletedPhase 1/2Johns Hopkins UniversityNCT01188421Written as Buprenorphine/naloxoneHow we know
- Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid DependenceCompletedPhase 3Orexo ABNCT01848054Written as BuprenorphineHow we know
- The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent SubjectsWithdrawnPhase 3BioDelivery Sciences InternationalNCT02516436Written as BuprenorphineHow we know
- A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid UsersCompletedPhase 1Alkermes, Inc.NCT02413281Written as BuprenorphineHow we know
- Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent AdolescentsWithdrawnPhase 4State University of New York at BuffaloNCT01015066Written as Buprenorphine/naloxoneHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
- Low-Dose IV Buprenorphine vs Hydromorphone for Acute Pain in the EDNov 17, 2026NCT07941505
Codes
What other systems call Buprenorphine · ClinicalTrials.gg INT007099
- MeSH (NLM) D002047BuprenorphineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 40D3SCR4GZBUPRENORPHINEConfirmed FDA, NLM, Wikidata
- RxNorm 1819Confirmed FDA, Wikidata
- Wikidata Q407721buprenorphineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61656BuprenorphineOne source FDA
- DrugBank DB00921One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002047 | Buprenorphine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 40D3SCR4GZ | BUPRENORPHINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1819 | — | Confirmed FDA, Wikidata |
| Wikidata | Q407721 | buprenorphine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61656 | Buprenorphine | One source FDA |
| DrugBank | DB00921 | — | One source Wikidata |
Also registered as buprenorphine hydrochloride (UNII 56W8MW3EN1 · RxNorm 203841).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.